The Australian Government has accepted advice from leading immunisation experts to make the Moderna (SPIKEVAX) COVID-19 vaccine available for children aged six years and older from 24 February 2022 – broadening the previous recommendation for children aged 12 years and older. The Australian Technical Advisory Group on Immunisation (ATAGI) recommendation follows the Therapeutic Goods Administration (TGA) approval of Moderna for children aged six years and older on 17 February 2022. Pfizer continues to be available to children aged five and over, and nearly half of children aged between five and…